Robert W. Baird initiated coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a research note issued on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $54.00 price target on the stock. Robert W. Baird’s target price points to a potential upside of 30.34% from the company’s previous close. […]
Baird R W upgraded shares of Astrana Health (NASDAQ:ASTH – Free Report) to a strong-buy rating in a research report released on Thursday morning, Zacks.com reports. A number of other research analysts also recently issued reports on the company. Jefferies Financial Group assumed coverage on Astrana Health in a research note on Monday, February 26th. […]
Astrana Health (NASDAQ:ASTH – Get Free Report) was upgraded by Baird R W to a “strong-buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. ASTH has been the topic of several other reports. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the […]
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") , a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value.
Astrana Health (NASDAQ:ASTH – Get Free Report) and Roma Green Finance (NASDAQ:ROMA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Earnings & Valuation This table compares Astrana […]